share_log

PharmaCyte Biotech | SC 13D: Statement of acquisition of beneficial ownership by individuals-PharmaCyte Biotech, Inc.(37.0%)

PharmaCyte Biotech | SC 13D:超过5%持股股东披露文件-PharmaCyte Biotech, Inc.(37.0%)

SEC announcement ·  2023/11/22 16:00
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息